1 (88) 100 11.5 Ϯ 1.5
The Egl phenotype and the presence of HSNs and extra cells in the anterior pharynx were scored as described in Experimental Procedures. The complete genotypes of the animals scored were, from top to bottom, as follows: N2 (wild-type), egl-1(n1084), egl-1(n1084) unc-76(e911)/ ϩϩ, nDf42/ϩ, egl-1(n1084)/nDf42, egl-1(n1084 n3082), egl-1(n1084) unc-76(e911)/egl-1(n1084 n3082), egl-1(n1084 n3082)/unc-42(e270) for the egg-laying phenotype and egl-1(n1084 n3082) /unc-76(e911) for the HSN and extra cells phenotype, egl-1(n1084 n3082)/nDf42. For comparison, ced-3(n717) animals have 10.7 Ϯ 1.7 (n ϭ 15), ced-4(n1162) animals 10.2 Ϯ 1.5 (n ϭ 15), and ced-9(n1950) animals 12.4 Ϯ 1.9 (n ϭ 15) extra cells in the anterior pharynx. ND, not determined. a Numbers represent averages Ϯ standard deviations.
these mutations were identified in screens for egg-laying seven mutations were not necessarily independent in origin, and all seven carry the same 5 bp deletion (see defective (Egl) mutants (Trent et al., 1983) . By isolating a dominant suppressor of the egl-1 Egl phenotype, we below). We assume that they derived from a single, possibly spontaneous, deletion event. The data presented identified an lf mutation in the egl-1 gene. This mutation prevents not only the ectopic deaths of the HSNs but below were therefore obtained from one representative isolate, which carries the allele n3082. most if not all normally occurring programmed cell deaths, indicating that egl-1 is a cell death activator
The n3082 mutation is a semidominant suppressor of egl-1(n1084): while 0% of hermaphrodites homozygous and encodes a component of the general cell death machinery in C. elegans.
for egl-1(n1084 n3082) are Egl, 66% of hermaphrodites homozygous for egl-1(n1084) but heterozygous for n3082 (i.e.,
of genotype egl-1[n1084 n3082]/egl-1[n1084])

Results
are Egl (Table 1) . Microscopic analyses using Nomarski optics revealed that the HSN neurons are present in An lf Mutation in egl-1 Blocks Programmed Cell Death egl-1(n1084 n3082) hermaphrodites, suggesting that the suppression of the Egl phenotype is caused by the supDominant mutations in the gene egl-1 cause the HSNs to undergo programmed cell death (Trent et al., 1983;  pression of the deaths of the HSNs (Table 1) .
To determine the effect of the n3082 mutation on cells Ellis and Horvitz, 1986 ). This ectopic cell death results in an Egl phenotype, as exemplified for the egl-1 allele that normally undergo programmed cell death in C. elegans, we determined the number of cells in the anterior n1084 in Table 1 . Hermaphrodites heterozygous for nDf42, a deficiency that deletes the egl-1 locus, do not pharynx of egl-1(n1084 n3082) animals at the third stage of larval development. Mutations that block proexhibit an Egl phenotype (Horvitz et al., 1994) (Table 1 ), indicating that the dominant mutations in egl-1 are not grammed cell death in C. elegans, such as a gf mutation in ced-9 or lf mutations in ced-4 or ced-3, result in the null mutations but rather are likely to be gf mutations. To date, seven egl-1(gf) mutations have been identified presence of 11-12 extra cells in the anterior pharynx . egl-1(n1084 n3082) animals (Trent et al., 1983; Desai and Horvitz, 1989; Horvitz et al., unpublished data) .
had on average 11.1 extra cells in the anterior pharynx (Table 1 ). This result indicates that the n3082 mutation To determine the lf phenotype of egl-1, we performed a screen for dominant suppressors of the egl-1 Egl phenot only blocks the ectopic deaths of the HSNs in egl-1(n1084) animals but, like the ced-9(gf), ced-4(lf), notype. Specifically, hermaphrodites homozygous for the mutation egl-1(n1084) were mutagenized with ethyl and ced-3(lf) mutations, also causes a general block in programmed cell death, that is, a Ced phenotype. methanesulfonate (EMS), allowed to self-fertilize, and their F1 progeny were screened for rare non-Egl animals.
This conclusion was supported by our analysis of egl-1(n1084 n3082) embryos for the presence of cell Since 68% of egl-1(n1084)/nDf42 heterozygous hermaphrodites were Egl (Table 1) , we reasoned that if one corpses in an engulfment-defective mutant background: a ced-1 mutation blocks the engulfment of the cell copy of the egl-1 gene in an egl-1(n1084) hermaphrodite were inactivated by an egl-1 lf mutation, the resulting corpses generated by programmed cell death and therefore allows a quantitative assessment of the number of animal should have about a one-third probability of being non-Egl. We analyzed 30,000 mutagenized haploid programmed cell deaths that have occurred as of a particular stage of development (Ellis et al., 1991b) . Emgenomes and isolated seven allelic suppressors that are closely linked to the egl-1 locus on chromosome V. All bryos homozygous for ced-1 or for ced-1; egl-1(n1084) had on average a total of 24.9 (n ϭ 15) and 24.1 (n ϭ seven suppressor mutations proved to be alleles of egl-1 (B. C. and H. R. H., unpublished data) and therefore 15) corpses at the 1 1/2-fold stage of embryogenesis, respectively. Homozygous ced-1; egl-1(n1084 n3082) represent intragenic revertants in the egl-1 gene. The Figure 1 . Localization of the egl-1 Locus (A) (Top) Genetic map. Genes and polymorphisms used for mapping the egl-1 locus are indicated. Numbers below the genetic map represent the fraction of the 76 recombination events identified between rol-4 and unc-76 that occurred between particular loci. (Middle) Physical map of the interval between nP88 and stP6. Cosmids tested for rescue are shown. The cosmids that detected nP88 (T20C8) and stP6 (KR#82), as well as the two rescuing cosmids (C01G9 and C03B12), are labeled. (Bottom) Partial restriction map of the right end of cosmid C01G9 and egl-1 rescue data obtained with various subclones. Transgenic animals carrying the indicated constructs as extrachromosomal arrays were generated, and rescue was scored as described in Experimental Procedures. The numbers of lines rescued and the total number of lines obtained are indicated in parentheses. The average numbers of corpses scored and the range of corpses (parentheses) for one representative line are also indicated (n ϭ 15). embryos, by contrast, contained only 0.1 corpses (n ϭ into egl-1(n1084 n3082) animals by germline transformation (Mello and Fire, 1995) and tested for their ability to 10) on average at this developmental stage.
The Ced phenotype of egl-1(n1084 n3082) animals is rescue the Ced phenotype. Rescue was assayed by analyzing transgenic animals for the presence of cell recessive: egl-1(n1084 n3082)/ϩ heterozygotes had only 1.0 extra cell (n ϭ 15) on average in the anterior pharynx corpses in embryos at the 1 1/2-fold stage of embryogenesis. To increase the sensitivity of the assay, (Table 1 ). In addition, the Ced phenotype of animals heterozygous for egl-1(n1084 n3082) and nDf42 (i.e., of the transgenic lines were established in a ced-1 mutant background to allow the persistence of cell corpses. genotype egl-1[n1084 n3082]/nDf42) was indistinguishable from that of egl-1(n1084 n3082) animals (Table 1) , Two overlapping cosmids, C01G9 and C03B12, both almost completely rescued the Ced phenotype caused suggesting that egl-1(n1084 n3082) is a strong lf allele and that egl-1 is required for programmed cell death in by the n1084 n3082 allele (as many as an average of 23.4 corpses in embryos; n ϭ 15). We narrowed this somatic tissues of C. elegans. Interestingly, cell death in the C. elegans germline did not seem to be affected rescuing activity to a 7.8 kb subclone of C01G9 contained in plasmid pBC08 (21.2 corpses; n ϭ 15) (Figure by the egl-1(n1084 n3082) mutation (our unpublished observations). 1A). A 2.5 kb subclone of pBC08, pBC11, also rescued the Ced phenotype but much less efficiently (1.5 corpses on average with a range of 0-11). Additional deletions Cloning of egl-1 completely abolished the residual rescuing activity (FigTo determine the molecular identity of egl-1, we cloned ure 1A). the gene by transformation rescue of the recessive Ced Using this minimal rescuing fragment as a probe, we phenotype of egl-1(n1084 n3082) homozygotes. First, screened an embryonic cDNA library and isolated two we used the Ced phenotype to map egl-1(n1084 n3082)
clones. The same probe detected a single approximately to the right arm of chromosome V between rol-4 and 650 bp message of low abundance in poly(A)ϩ mRNA unc-76 (data not shown), the interval to which egl-1(gf) isolated from embryos and L1 larvae but not from later mutations were mapped previously (Trent et al., 1983;  larval stages or young adults (data not shown). Using Desai and Horvitz, 1989) . We further mapped egl-1(n1084 reverse transcriptase-polymerase chain reaction (RTn3082) between the restriction fragment length polymor-PCR) and anchored reverse-transcriptase PCR (RACE; phisms (RFLPs) nP88 on cosmid T20C8 and stP6 on rapid amplification of cDNA ends), we determined the cosmid KR#82 (Williams et al., 1992 ) ( Figure 1A ). Cosmids that map between nP88 and stP6 were introduced complete structure and sequence of the transcript, which has two coding exons and two potential initiator unpublished observations). The truncated EGL-1 protein predicted to be formed in egl-1(n1084 n3082) animals codons, of which we predict the more 3Ј ATG to be used in vivo ( Figure 1B and Figure 2A , data not shown).
lacks this BH3-like region and the C terminus of theprotein. Frameshift mutations introduced into the genomic fragment contained in pBC13 confirmed that this transcript egl-1 Null Phenotype was responsible for the rescuing activity (data not
The observation that animals homozygous for egl-1(n1084 shown). Furthermore, the expression of the predicted n3082) have the same number of extra cells in the antecoding region under the control of a C. elegans heatrior pharynx as animals trans-heterozygous for eglshock promoter (P hsp ; Mello and Fire, 1995) was sufficient 1(n1084 n3082) and nDf42 (Table 1) suggests that the to rescue the Ced phenotype of ced-1; egl-1(n1084 n3082 mutation results in at least a severe loss of the n3082) animals. Transgenic ced-1; egl-1(n1084 n3082) normal function of the EGL-1 protein. Furthermore, othembryos carrying extrachromosomal arrays containing ers have observed that embryos homozygous for defithe P hsp egl-1 construct contained up to 31.9 corpses ciencies that uncover loci to the left and right of the on average at the 1 1/2-fold stage after being subjected egl-1 locus, and therefore that presumably delete egl-1, to heat shock (Table 2) . lack cell corpses (J. Rothman, personal communication) To confirm that the identified gene is egl-1, we deterand contain up to 40% more nuclei than do wild-type mined the nucleotide sequence of the gene for each embryos (M. Labouesse, personal communication), indiof the seven egl-1(gf) suppressors we had isolated. All cating that a total loss of the egl-1 region results in a seven alleles had an identical 5 bp deletion at the beginblock in programmed cell death. We have observed that ning of exon 2 ( Figure 2A ). This deletion is predicted to result in a frameshift leading to the generation of a truncated protein composed of the first half of the wild- containing proteins, the BH3-like region of EGL-1 is preFor each experiment, 10-15 animals were scored.
dicted to adopt the structure of an amphipathic ␣-helix (our corpses; n ϭ 10) and therefore are cell death defective.
(gf) was ced-9(n1950), ced-4 (lf) was ced-4(n1162), and ced-3 (lf) was ced-3(n717).
By contrast, embryos homozygous for deficiencies that delete regions to the left or right of the egl-1 locus, such as lwDf3 or yDf11, have an average of 8.3 (n ϭ 10) and 5.2 (n ϭ 10) corpses, respectively. These observations egl-1 (P mec-7 egl-1 A-C), only about 10% of the ALM neurons were present (Table 4) . By contrast, almost all ALMs are consistent with the hypothesis that the complete inactivation of the egl-1 locus results in a block in prosurvived in animals either carrying an extrachromosomal array with the Pmec-7 vector (Table 4 , Pmec-7 A and B) or grammed cell death. However, since nDf42, yDf8, zuDf2, and itDf2 cause not only a Ced phenotype but also homozygous for an integrated Pmec-7 lacZ fusion construct (Shaham and Horvitz, 1996a) . The egl-1-induced embryonic lethality, it is possible that egl-1(n1084 n3082) is not a null mutation and that a null allele of egl-1 would killing of the ALMs was dependent on the number of copies of the egl-1 gene: 50% of the ALMs survived in result in some additional phenotypic abnormality, such as embryonic lethality.
animals heterozygous for Pmec-7 egl-1 C (Pmec-7 egl-1 C/ϩ). egl-1-induced killing was completely blocked by lf mutations in ced-4 or ced-3 ( Table 4 ), confirming that eglegl-1 Acts Downstream of or in Parallel to the Genes Involved in Cell 1-induced killing involved the known cell death pathway.
That egl-1 required the activities of ced-3 and ced-4 to
Death Specification
To determine at what stage in the well characterized induce killing indicates that egl-1 functions upstream of or in parallel to ced-4 and ced-3. This conclusion is C. elegans genetic pathway for programmed cell death egl-1 acts, we performed epistasis analysis. We first supported by the observation that the egl-1(gf) phenotype, the ectopic deaths of the HSN neurons in hermaphconstructed double mutants between egl-1 and the cell death-specification gene ces-1, which acts downstream rodites, is suppressed by lf mutations in either ced-4 or ced-3 (Trent et al., 1983; Ellis and Horvitz, 1986) . of the cell death-specification gene ces-2 (Ellis and Horvitz, 1991) . In animals carrying an lf mutation in ces-1, the sisters of the NSM neurons in the pharynx undergo egl-1 Functions through ced-9
The lethality caused by lf mutations in the cell death inhibprogrammed cell death (Ellis and Horvitz, 1991) ; these cells survive in egl-1(n1084 n3082) animals (Table 3) .
itor gene ced-9 is suppressed by lf mutations in either ced-4 or ced-3, genes thought to act downstream of We found that the NSM sisters also survived in ces-1(lf); egl-1(n1084 n3082) double mutant animals, indicating ced-9. To determine where egl-1 acts with respect to ced-9, we tested the viability of a ced-9(lf); egl-1(n1084 that the egl-1(n1084 n3082) allele is epistatic to the ces-1(lf) mutation and suggesting that egl-1 acts downn3082) double mutant strain. We found that this strain was inviable, indicating that an egl-1(lf) mutation did not stream of or in parallel to ces-1.
suppress ced-9(lf)-induced lethality. egl-1 is therefore likely to act upstream of or in parallel to ced-9. egl-1-egl-1 Acts Upstream of or in Parallel to ced-4 and ced-3 induced killing of the ALM neurons (see above) was suppressed by the ced-9 gf mutation n1950 (Table 4) , Pmec-7 is a C. elegans promoter that becomes activated in a small number of cells, including the six touch cells, supporting this conclusion.
To characterize the role of ced-9 in egl-1-induced cell neurons involved in mechanosensation (Hamelin et al., 1992) . Like ced-3 or ced-4 cDNAs (Shaham and Horvitz, killing in more detail, we tested whether the block in cell death caused by the egl-1(n1084 n3082) allele is affected 1996a), an egl-1 cDNA expressed under the control of P mec-7 can induce the C. elegans touch cells (including by a ced-9(lf) mutation. If egl-1 acts through ced-9, the egl-1(n1084 n3082) mutation should prevent cell death the ALM neurons), which normally survive, to undergo programmed cell death (Table 4) . We used this ectopic only in the presence of a functional ced-9 gene. On the other hand, if egl-1 acts in parallel to ced-9, a ced-9 killing to determine the stage at which egl-1 acts with respect to ced-4 and ced-3.
(lf) mutation might not affect the ability of egl-1(n1084 n3082) to block cell death. In animals homozygous for integrated arrays of P mec-7
Because a ced-9 null mutation, ced-9(0), is lethal (in both an egl-1 [ϩ] and egl-1[n1084 n3082] background), we could not directly compare the effects of a ced-9(0) mutation on cell death in egl-1(ϩ) and egl-1(n1084 n3082) animals. Instead, we did this comparison in the background of the weak ced-3 lf mutation n2427, which suppresses the lethality of a ced-9(0) mutation. The ced-3(n2427) mutation weakly inhibits programmed cell death and resulted in 1.6 Ϯ 0.8 (average Ϯ standard deviation, n ϭ 15) extra cells in the anterior pharynx. In the background of the ced-3(n2427) mutation, as in a ced-3(ϩ) background, the egl-1(n1084 n3082) allele resulted in 11.1 Ϯ 1.7 extra cells (n ϭ 15). Using a ced-9(0); ced-3(n2427) double mutant background, we assessed the death-inducing activity of egl-1 in the absence of ced-9 function. ced-9(0); ced-3(n2427) animals carrying the egl-1(ϩ) allele had an average of 6.3 Ϯ 2.9 extra cells in the anterior pharynx (n ϭ 15). Mutant animals additionally carrying the egl-1(n1084 n3082) allele had an average of 7.0 Ϯ 1.5 extra cells (n ϭ 15). Thus, the presence of egl-1 activity did not affect programmed not only have a cell death protective activity but also a (B) The interaction between CED-9 and EGL-1 depends on the BH3-cell death promoting activity (Hengartner and Horvitz, like region of EGL-1.
35
S-labeled S·TAG-EGL-1 (lanes 1 and 4) , S·TAG-EGL-1 with a deletion of the BH3-like region (S·TAG-EGL-1 1994a). ⌬BH3) (lanes 2 and 5; 13.4 kDa), or S·TAG-EGL-1 protein encoded by the egl-1(n1084 n3082) allele (which causes a frameshift and EGL-1 and CED-9 Physically Interact premature termination) (S·TAG-EGL-1 trunc) (lanes 3 and 6; 11.2
The mammalian BH3-containing proteins Bik, Bid, HarakDa) were incubated with GST-CED-9 (lanes 1-3) or GST alone (lanes kiri, and Bad physically interact with members of the 4-6) and analyzed for binding. Lanes 7-9 represent 10% of the input Bcl-2 family of proteins (Boyd et al., 1995; Yang et al., of S·TAG-EGL-1 (lane 7), S·TAG-EGL-1 ⌬BH3 (lane 8), or S·TAG-EGL-1 trunc (lane 9). Forty percent of the GST-CED-9 and GST 1995; Han et al., 1996a; Wang et al., 1996; Inohara et proteins are shown in lanes 10 and 11 (15% SDS-PAGE, stained al., 1997; Kelekar et al., 1997; Ottilie et al., 1997b; with Coomassie blue). et al., 1997). To determine whether the EGL-1 and CED-9 proteins can directly bind to each other, we first used a yeast two-hybrid system based on the DNA-binding then reisolated and analyzed for associated 35 S-S·TAG-and transactivation domain of the yeast GAL4 protein EGL-1 by SDS-PAGE and autoradiography. As shown (Bai and Elledge, 1996) . Clones transformed with either in Figure 3A , GST-CED-9 interacted with S·TAG-EGL-1 the EGL-1-GAL4 transactivation fusion or the CED-9-but not with any of the control proteins tested, such GAL4 DNA-binding domain fusion alone did not turn as S·TAG alone, luciferase, or the yeast protein SSN6. blue even after extended periods of incubation using Furthermore, incubation of GST alone with S·TAG-EGL-1 a ␤-galactosidase-filter assay and had no detectable did not result in binding, indicating that the observed ␤-galactosidase activity when measured more quantitabinding is specific for the CED-9 and EGL-1 proteins. tively in liquid (0.2 Ϯ 0.2 and 0.1 Ϯ 0.1 units/OD600 Ϯ The BH3 domain is involved in the binding of BH3-standard deviations, respectively). By contrast, clones containing proteins to members of the Bcl-2 family of transformed with both fusions turned blue in fewer than proteins (Han et al., 1996b; Wang et al., 1996 ; Inohara 30 min and had 32.0 Ϯ 2.7 units of ␤-galactosidase et al., 1997; Kelekar et al., 1997; Ottilie et al., 1997b ; Zha activity/OD600, suggesting that the EGL-1 protein and et al. , 1997) . To analyze the role of the BH3-like region the CED-9 protein interacted in this system. We conof EGL-1 in the interaction between EGL-1 and CED-9, firmed this result by examining the interaction of these we tested mutant EGL-1 proteins in the in vitro binding two proteins in vitro. Glutathione S-transferase (GST)-assay. EGL-1 protein that lacks the nine residues similar tagged CED-9 (GST-CED-9) or GST alone was affinity to the BH3 domain of Bcl-2-like and BH3-containing purified and incubated with in vitro transcribed and proteins (S·TAG-EGL-1 ⌬BH3) had a reduced ability translated 35 S-methionine-labeled tagged EGL-1 protein ( 35 S-S·TAG-EGL-1). GST-CED-9 or GST alone was to bind to GST-CED-9 ( Figure 3B ). The interaction of S·TAG-EGL-1 with GST-CED-9 was completely elimiis a poor target for EMS or that the egl-1 null phenotype is not simply a block in cell death but includes other nated by the introduction into the EGL-1 protein of the egl-1(lf) mutation n3082 (S·TAG-EGL-1 trunc), which, as defects, such as embryonic lethality. described above, is a 5 bp deletion predicted to result in the formation of a truncated EGL-1 protein lacking egl-1 Might Integrate Cell Death-Inducing Signals the putative BH3 domain and the C terminus of the The egl-1 gene is the earliest acting component of the protein. These results suggest that the BH3-like region central cell death machinery identified in C. elegans so of EGL-1 is required for efficient binding of EGL-1 to far. egl-1 functions upstream of ced-9, ced-4, and ced-3 CED-9.
and downstream of or in parallel to ces-2 and ces-1, two C. elegans genes thought to be involved in specifying the cell death fate of a subset of cells, such as the sister Discussion cells of the pharyngeal NSM neurons ( Figure 4A ). It is possible that egl-1 is a direct target of ces-1 and/or of Why Were egl-1(lf) Alleles Not Identified Previously?
ces-2, which encodes a protein with a bZIP (basic reBy isolating a lf mutation in egl-1, we have identified a gion/leucine zipper) DNA-binding domain similar to that fourth component of the central cell death machinery in of the human hepatic leukemia factor (HLF) (Metzstein C. elegans. Previous screens that could have identified et al. , 1996) . gf mutations in egl-1 lead to the deaths of mutants with a general cell death block like that of egl-1 the HSN neurons, which are required for egg laying and (n1084 n3082) yielded a gf mutation in ced-9 and numerwhich normally survive in hermaphrodites but undergo ous lf mutations in ced-3 and ced-4 but no lf mutation programmed cell death in males (Sulston and Horvitz, in egl-1 (Ellis and Horvitz, 1986; Sulston et al., 1983) . This phenotype might be Horvitz et al., unpublished observations). The previous caused by a defect in the regulation of egl-1 activity by failure to isolate such mutations might be explained in a ces-1-or ces-2-like factor that normally specifies the a number of ways.
sexually dimorphic life-versus-death fate of the HSNs. egl-1 is only about one-fifth the size of the average
The egl-1 gene thus appears to act at the point of the C. elegans gene and hence provides a small target.
cell death pathway at which signals that determine the Nonetheless, a large number of EMS-mutagenized hapcell death fate in C. elegans are integrated to specify loid genomes have been screened (we examined at least which cells activate the process of programmed cell 45,000 such genomes; our unpublished results), and death. given that the average gene mutates to lf at a frequency of about 1 per 2,000 EMS-mutagenized haploid genomes (reviewed by Anderson, 1995) , egl-1 target size EGL-1 May Act by Antagonizing CED-9 EGL-1 might be a new member of the BH3 only-conalone seems unlikely to be responsible. Perhaps the small egl-1 gene contains no sites readily mutable by taining group of cell death activators, which includes Bik, Bid, Harakiri, and Bad (Boyd et al., 1995; Yang et EMS, which predominantly induces GC-to-AT transition mutations and mutates different GC base pairs at very al., 1995; Han et al., 1996a; Wang et al., 1996; Inohara et al., 1997; Kelekar et al., 1997; Ottilie et al., 1997b ; Zha different frequencies (Coulondre and Miller, 1977) .
Alternatively, as described above, the n3082 mutation et al., 1997). Various models have been proposed for how BH3 only-containing cell death activators induce might not be a null mutation, and an egl-1 null mutation might cause a phenotype in addition to the block in cell death. In the cases of Bik, Harakiri, and Bad, for example, all of which bind to Bcl-2-like cell death inhibiprogrammed cell death, such as embryonic lethality. The screens performed previously for mutants with a tors, deletions of, or mutations within the BH3 domains reduce or eliminate both their abilities to bind to Bclgeneral cell death block would not have identified inviable cell death defective mutants. It is also conceivable 2-like cell death inhibitors and to induce cell death Han et al., 1996a; Inohara et al., that n1084 n3082 is an altered-function (neomorphic) allele and results in an egl-1 gf phenotype such that the 1997; Kelekar et al., 1997; Zha et al., 1997) . This result suggests that Bik, Harakiri, and Bad induce death by novel mutant EGL-1 protein interferes with the pathway for programmed cell death. This possiblity seems unbinding to and blocking Bcl-2-like cell death inhibitors. The situation appears different in the case of Bid, which likely for three reasons: gene-dosage experiments suggest that n1084 n3082 is an lf allele; deficiencies that binds to both the cell death inhibitor Bcl-2 and to the cell death activator Bax (Wang et al., 1996) . Analysis of span egl-1 when homozygous lead to a block in cell death; and the ectopic expression of wild-type egl-1 the BH3 domain of Bid resulted in the identification of mutations that block the ability of Bid to bind to Bcl-2 can induce cell death.
Another possibility is that the egl-1(n1084 n3082) chrobut do not affect its capacity to bind to Bax and to induce cell death, and vice versa. These data favor a mosome contains an additional mutation that in combination with this egl-1 allele prevents programmed cell model in which a Bid/Bax heterodimer is the functional cell death effector, which might be antagonized by the death. If so, based upon our analyses of the phenotype of egl-1(n1084 n3082)/deficiency heterozygotes, this cell death inhibitor Bcl-2. How might EGL-1 function to engage the cell death second gene would have to be located within a region of less than 0.5 map units on the genetic map and about machinery and cause cell death in C. elegans? Our data indicate that EGL-1 requires the activities of CED-4 and 1 Mb on the physical map (our unpublished observations).
of the caspase CED-3 to trigger cell death and that EGL-1 acts through the Bcl-2-like protein CED-9 ( Figure  We prefer the possibilities that either the egl-1 gene 4A). It has been suggested that CED-9 and CED-4 exist of the Bcl-2 family can be disrupted by the presence of BH3-containing cell death-activating proteins or pepin a membrane-associated complex and that the association of CED-9 with CED-4 in this complex prevents tides is indicated by the observation that the interaction between Bcl-x L and CED-4 in vitro can be blocked by CED-4 from activating the caspase CED-3 and initiating programmed cell death (reviewed by Jacobson, 1997;  Bax, Bak, Bik, or a Bak-derived BH3 peptide (Chinnaiyan et al., 1997a; Ottilie et al., 1997a) . Vaux, 1997) . We propose that EGL-1 triggers cell death by binding to CED-9. This interaction might result in the Our studies demonstrate that EGL-1 plays a major role in controlling programmed cell death in C. elegans displacement of CED-4 from a membrane-associated complex, thereby allowing CED-4 to initiate cell death by acting as a negative regulator of the Bcl-2-like cell death inhibitor CED-9. Although we believe that EGL-1 ( Figure 4B ). EGL-1 might therefore act to antagonize the ability of CED-9 to block CED-4.
induces cell death by displacing CED-4 from CED-9, this model may be an oversimplification, since additional This model is based on the following observations. First, EGL-1 interacts with CED-9, both in a two-hybrid Bcl-2-like molecules might exist in C. elegans, an antiapoptotic isoform of CED-4, called CED-4L, has been system and in vitro. This interaction is abolished by the egl-1(lf) mutation n3082, which causes a Ced phenotype described (Shaham and Horvitz, 1996b) , and CED-9 can act as a substrate for the CED-3 caspase (Xue and Horin vivo. These observations are consistent with the hypothesis that the ability of EGL-1 to bind to CED-9 is vitz, 1997). These considerations indicate that the control of programmed cell death in C. elegans may well required for the ability of EGL-1 to induce killing in vivo. Second, it seems likely that CED-9 cannot bind to EGL-1 be more complex. and CED-4 simultaneously. The BH1, BH2, and BH3
Experimental Procedures
domains of Bcl-2 are required for Bcl-2 to interact with Bax (Yin et al., 1994; Hunter et al., 1996; Zha et al., 1996;  General Methods and Strains Diaz et al., 1997) , Bak , and C. elegans strains were maintained as described by Brenner (1974) .
Bad (Zha et al, 1997) , and the BH1, BH2, and BH3 doThe wild-type strain generally used was N2 (Bristol). The wild-type mains of Bcl-x L are necessary for the interaction of Bcl-x L strain RW7000 (Bergerac) was used in conjunction with N2 for RFLP analysis. Mutations used in this study are listed below and are with Bak and Bad (Kelekar et described by Riddle et al. (1997) , except where noted otherwise.
al., 1997). Furthermore, when complexed with a Bak-
LGI: ced-1(e1735), ces-1(n703 n1434) (Ellis and Horvitz, 1991) . LGIII: derived BH3 peptide, the BH1, BH2, and BH3 domains ced-4(n1162), ced-9(n1950), ced-9(n2812) (Shaham and Horvitz, of Bcl-x L form an elongated hydrophobic pocket, which LGV : unc-42(e270), rol-4(sc8) , egla ligand (Muchmore et al., 1996; Sattler et al., 1997) .
1(n1084), egl-1(n1084 n3082) (this study), unc-76(e911). Deficiencies used were as follows: nDf42 (M. O. Hengartner and H. R. H., unpubConsidering the overall sequence similarities among lished results), yDf8 and yDf11 (DeLong et al., 1993) , itDf2 (K.
Bcl-2, Bcl-xL, and CED-9 and the fact that EGL-1 conKemphues, personal communication), zuDf2 (Zhu et al., 1997) , and tains a region similar to the BH3 domains of Bax, Bak, lwDf3 (M. Moseley and J. Shaw, personal communication). Allele and Bad, it seems likely that the interaction between designations for the integrated lines are as follows: Pmec-7 egl-1A is CED-9 and EGL-1 is mediated by the BH1, BH2, and BH3 nIs94; Pmec-7 egl-1B is nIs95; and Pmec-7 egl-1C is nIs91.
domains of CED-9. The sequence requirement of CED-9 for its interaction with CED-4 has recently been analyzed Mapping of egl-1(n1084 n3082) Standard genetic techniques were used to map egl-1(n1084 n3082) using two-hybrid analysis (Ottilie et al., 1997a) , and the to LGV between rol-4 and unc-76 (Brenner, 1974; Williams et al., results suggest that all four BH domains of CED-9 are 1992). Various cosmids in the rol-4 to unc-76 interval were tested necessary for CED-9 to bind efficiently to CED-4. Tofor their abilities to detect RFLPs between N2 and RW7000. Cosmid gether, these observations suggest that the CED-9-T20C8 was found to detect a RFLP that we named nP88 (EcoRI binding sites for EGL-1 and CED-4 might be largely digest) (our unpublished result). The position of n1084 n3082 with respect to nP88 and stP6 was determined as described by Ruvkun overlapping. That CED-4 binding to cell death inhibitors et al. (1989) . Briefly, recombinants for LGV between N2 and RW7000 1990). The sequences of all constructs generated by PCR amplification used throughout this study were confirmed by DNA sequencing. were obtained by screening the progeny of rol-4(sc8) egl-1(n1084 n3082) unc-76(e911) (N2)/ϩ (RW7000) animals for Rol non-Unc and Wild-type and mutant egl-1 cDNAs were cloned into vector pCITE4a(ϩ) (Novagen) such that the resulting fusion protein was tagged Unc non-Rol animals. Homozygous recombinants were scored for n1084 n3082, nP88, and stP6.
with the S·TAG (Novagen) and transcribed and translated in vitro in the presence of 35 S-methionine using a T7-based coupled reticulocyte lysate (TNT Coupled Reticulocyte Lysate System, Promega).
Transgenic Animals
For GST-CED-9, the ced-9 cDNA was cloned into vector pGEXGermline transformation experiments were performed as described , expressed in BL21(DE3) cells, and purified using by Mello and Fire (1995) . For egl-1(n1084 n3082) rescue with genoglutathione sepharose as suggested by the manufacturer (Pharmic DNA, we injected ced-1(e1735); egl-1(n1084 n3082) uncmacia). 35 S-labeled S·TAG-EGL-1 and purified GST-CED-9 were in-76(e911) animals with genomic DNA contained in cosmids or cubated for 30-60 min at 4ЊC in 500 l binding buffer (142.5 mM plasmids (1-10 g/ml) and the coinjection marker p76-16B, which KCl, 10 mM HEPES [pH 7.6], 5 mM MgCl 2, 1 mM EDTA, 0.25% rescues unc-76 (50 g/ml) (Bloom and Horvitz, 1997). Non-Unc IGEPAL CA-630/Sigma, 2.5 mg/ml BSA). Protein complexes were transgenic F1 animals were identified and lines established. For eglwashed 3ϫ with 1 ml binding buffer, 1ϫ with 1 ml binding buffer 1(n1084 n3082) rescue with the egl-1 cDNA under the control of the without BSA, resuspended in 25 l of 2ϫ sample buffer, and ana-C. elegans heat-shock promoters (P hsp ), we injected ced-1(e1735); lyzed by SDS-PAGE (15%) and autoradiography. egl-1(n1084 n3082) unc-76(e911) animals with the 276 bp cDNA transcriptionally fused to P hsp in the vectors pPD49.78 and pPD49.83
